Yasukawa, M.; Fujihara, H.; Fujimori, H.; Kawaguchi, K.; Yamada, H.; Nakayama, R.; Yamamoto, N.; Kishi, Y.; Hamada, Y.; Masutani, M.
Synergetic Effects of PARP Inhibitor AZD2281 and Cisplatin in Oral Squamous Cell Carcinoma in Vitro and in Vivo. Int. J. Mol. Sci. 2016, 17, 272.
https://doi.org/10.3390/ijms17030272
AMA Style
Yasukawa M, Fujihara H, Fujimori H, Kawaguchi K, Yamada H, Nakayama R, Yamamoto N, Kishi Y, Hamada Y, Masutani M.
Synergetic Effects of PARP Inhibitor AZD2281 and Cisplatin in Oral Squamous Cell Carcinoma in Vitro and in Vivo. International Journal of Molecular Sciences. 2016; 17(3):272.
https://doi.org/10.3390/ijms17030272
Chicago/Turabian Style
Yasukawa, Masaaki, Hisako Fujihara, Hiroaki Fujimori, Koji Kawaguchi, Hiroyuki Yamada, Ryoko Nakayama, Nanami Yamamoto, Yuta Kishi, Yoshiki Hamada, and Mitsuko Masutani.
2016. "Synergetic Effects of PARP Inhibitor AZD2281 and Cisplatin in Oral Squamous Cell Carcinoma in Vitro and in Vivo" International Journal of Molecular Sciences 17, no. 3: 272.
https://doi.org/10.3390/ijms17030272
APA Style
Yasukawa, M., Fujihara, H., Fujimori, H., Kawaguchi, K., Yamada, H., Nakayama, R., Yamamoto, N., Kishi, Y., Hamada, Y., & Masutani, M.
(2016). Synergetic Effects of PARP Inhibitor AZD2281 and Cisplatin in Oral Squamous Cell Carcinoma in Vitro and in Vivo. International Journal of Molecular Sciences, 17(3), 272.
https://doi.org/10.3390/ijms17030272
